FDA warns e-cig­a­rette com­pany on use of erec­tile dys­func­tion drug

The Commercial Appeal - - Front Page - Ryan W. Miller USA TO­DAY

The Food and Drug Ad­min­is­tra­tion is­sued a warn­ing last week to an e-cig­a­rette com­pany that it says sold va­p­ing e-liq­uid prod­ucts con­tain­ing the ac­tive in­gre­di­ents in erec­tile dys­func­tion drugs Cialis and Vi­a­gra.

The FDA gave China-based Hel­loCig Elec­tronic Tech­nol­ogy Co., Ltd. 15 days to ad­dress con­cerns some of its prod­ucts used “un­ap­proved new drugs.”

“E-Cialis Hel­loCig E-Liq­uid” con­tained silde­nafil (ac­tive in Vi­a­gra) and tadalafil (ac­tive in Cialis). “E-Ri­mon­a­bant Hel­loCig E-Liq­uid” con­tained silde­nafil, the FDA said a lab anal­y­sis of the e-liq­uids con­firmed.

Both Cialis and Vi­a­gra are FDA-ap­proved drugs, but they are not ap­proved to be added to e-cig­a­rette liq­uids.

The link the FDA in­cluded in its let­ter was no longer on the com­pany’s web­site when USA TO­DAY tried to ac­cess it Fri­day evening. Hel­loCig also did not re­spond im­me­di­ately to USA TO­DAY’s re­quest for com­ment.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.